Project Details
Description
MT2024-01:A First-In-Human, Open-Label, Multicenter Study of VOR33 in Patients with Acute Myeloid Leukemia who are at High-Risk for Leukemia Relapse following Hematopoietic Cell Transplantation
| Status | Active |
|---|---|
| Effective start/end date | 7/10/24 → 1/31/34 |
Funding
- VOR BIOPHARMA, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.